Yervoy and Polymyalgia rheumatica aggravated - a phase IV clinical study of FDA data

Summary:

Polymyalgia rheumatica aggravated is reported as a side effect among people who take Yervoy (ipilimumab), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Opdivo, and have Malignant melanoma.

The phase IV clinical study analyzes which people have Polymyalgia rheumatica aggravated when taking Yervoy. It is created by eHealthMe based on reports of 26,647 people who have side effects when taking Yervoy from the FDA, and is updated regularly.

What is Yervoy?

Yervoy has active ingredients of ipilimumab. eHealthMe is studying from 26,662 Yervoy users. Check the latest studies of Yervoy.

What is Polymyalgia rheumatica aggravated?

Polymyalgia rheumatica aggravated (serious pain in many muscles) is found to be associated with 377 drugs and 336 conditions by eHealthMe. Check the latest studies of Polymyalgia rheumatica aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 13, 2026

26,647 people reported to have side effects when taking Yervoy.
Among them, 35 people (0.13%) have Polymyalgia rheumatica aggravated.

Could Yervoy cause Polymyalgia rheumatica aggravated?

Among these 35 people:

How long have people been on Yervoy when they have Polymyalgia rheumatica aggravated? *

What is the gender of people who have Polymyalgia rheumatica aggravated when taking Yervoy? *

female: 3.57 %
male: 96.43 %

What is the age of people who have Polymyalgia rheumatica aggravated when taking Yervoy? *

What are other drugs people take besides Yervoy? *

Opdivo: 27 people, 77.14%
Sitagliptin: 6 people, 17.14%
Magnesium Oxide: 4 people, 11.43%
Carboplatin: 4 people, 11.43%
Tizanidine Hydrochloride: 4 people, 11.43%
Acetaminophen: 3 people, 8.57%
Simvastatin: 3 people, 8.57%
Prednisolone: 2 people, 5.71%
Lansoprazole: 2 people, 5.71%
Alimta: 2 people, 5.71%

What are other side effects people have besides Polymyalgia rheumatica aggravated? *

Colitis (inflammation of colon): 8 people, 22.86%
Thyroid Diseases: 8 people, 22.86%
Malignant Neoplasm Progression (cancer tumour came back): 8 people, 22.86%
Intestinal Obstruction: 7 people, 20.00%
Cytomegalovirus Enterocolitis (virus infection of intestine and colon): 7 people, 20.00%
Diarrhea: 7 people, 20.00%
Autonomic Neuropathy (malfunction of the autonomic nervous system (ans)): 6 people, 17.14%
Fever: 6 people, 17.14%
Renal Disorder (kidney disease): 6 people, 17.14%
Muscle Aches (muscle pain): 6 people, 17.14%

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 18 people, 51.43%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 6 people, 17.14%
Type 2 Diabetes: 4 people, 11.43%
Colitis (inflammation of colon): 3 people, 8.57%
Oesophageal Carcinoma (cancer tumour of oesophagus): 2 people, 5.71%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 5.71%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 5.71%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 5.71%
Renal Cell Carcinoma (a kidney cancer): 1 person, 2.86%
Pleural Mesothelioma Malignant (cancer of the pleura, or the membrane that lines the lungs): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Yervoy and have Polymyalgia rheumatica aggravated?

- Check whether Polymyalgia rheumatica aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Yervoy:

Yervoy (26,662 reports)

Browse all side effects of Yervoy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Polymyalgia rheumatica aggravated:

Polymyalgia rheumatica aggravated (377 drugs)

Browse all the conditions that are associated with Polymyalgia rheumatica aggravated:

Polymyalgia rheumatica aggravated (336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ipilimumab (the active ingredients of Yervoy) and Yervoy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.